Show simple item record

dc.contributorAl Awaidy, S.EN
dc.contributorBawikar, S.EN
dc.contributorPrakash, K.P.EN
dc.contributorAl Rawahi, B.EN
dc.contributorMohammed, A.J.EN
dc.date.accessioned2014-06-17T09:10:54Z
dc.date.available2014-06-17T09:10:54Z
dc.date.issued2010EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/V16/05/16_5_2010_0474_0480.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/117901
dc.description474-480EN
dc.description.abstractA descriptive record-based review of adverse events following immunization [‎AEFI]‎ was carried out in Oman using the national database for the period 1996-2005. A total of 790 adverse event reports were received with an annual rate during the review period of 33.7 per 100000 population or 10.8 per 100000 doses administered. There were no reported deaths. The most frequently reported AEFI were BCG adenitis [‎69.7 per 100000 doses]‎ and local reactions [‎3.6 per 100000 doses respectively]‎. The statistically significant higher rates among males, in children aged > 2 years and in some sparsely populated regions of Oman need further research. AEFI rates in Oman were similar or below the international averagesEN
dc.language.isoenEN
dc.subjectImmunization ProgramsEN
dc.subjectInjections, IntradermalEN
dc.subjectRisk AssessmentEN
dc.subjectVaccinesEN
dc.subjectDeveloping CountriesEN
dc.subject.meshImmunizationEN
dc.titleSurveillance of adverse events following immunization: 10 years' experience in OmanEN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 16 (‎5)‎, 474-480, 2010


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record